Antigen Discovery Company
ANTIGEN DISCOVERY, INC. AWARDED PHASE II SBIR GRANT TO IDENTIFY BIOMARKERS ASSOCIATED WITH PROTECTION AGAINST MALARIA
Technology:
Immunological Biomarkers
Estimated Revenue:
$10M to $50M
Founded Date:
2004
Industry:
Omics-based
Number Of Exists:
11-50
Headquarters:
Irvine, California, United States